Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.13M $50.94M March 31, 2014
Palo Alto Investors 5.17M $20.06M March 31, 2014
OppenheimerFunds 5.00M $19.40M March 31, 2014
Broadfin Capital 4.96M $14.12M Dec. 31, 2013
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
Wellington Management Company 4.47M $17.36M March 31, 2014
Vanguard 4.11M $15.96M March 31, 2014
BlackRock Fund Advisors 3.50M $13.59M March 31, 2014
NEA Management Company 3.24M $12.58M March 31, 2014
BlackRock Institutional Trust Company, N.A. 3.18M $12.36M March 31, 2014
Deerfield Management Company 2.71M $9.05M June 30, 2013
BVF 2.58M $10.00M March 31, 2014
Millennium Management 2.27M $8.79M March 31, 2014
Visium Asset Management 2.01M $5.73M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.90M $7.37M March 31, 2014
HealthCor Management 1.80M $14.49M March 31, 2012
D. E. Shaw & Co 1.62M $6.30M March 31, 2014
MORGAN STANLEY 1.52M $5.86M March 31, 2014
STATE STREET CORPORATION 1.50M $5.82M March 31, 2014
HealthCor Management 1.50M $13.76M June 30, 2011
Balyasny Asset Management 1.34M $3.81M Dec. 31, 2013
NORTHERN TRUST 1.22M $3.48M Dec. 31, 2013

Who sold Rigel Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ameriprise Financial June 30, 2011 1.26M $11.59M